Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Google added a very useful feature to the Google Search Console Insights report named query groups. It does what it is named, it groups similar queries together as one, so you can see how your site is ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

So far this year, electricity use in the US is up nearly 4 percent compared to the same period the year prior. That comes after decades of essentially flat use, a change that has been associated with ...

The first release candidate (RC0) of SQL Server 2025 is now available. As we move toward general availability, our focus shifts to delivering enhanced stability, performance, and product improvements ...

At Microsoft Build 2025, we announced the public preview of SQL Server 2025. Built on a foundation of best-in-class security, performance, and availability, SQL Server 2025 empowers customers to ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...

What if machines could not only learn but also teach themselves to become better with each iteration? This isn’t the plot of a sci-fi movie—it’s the reality unfolding in artificial intelligence ...